Medication Brands

American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.

Prescription immunosuppressant medication for treating relapsing-remitting multiple sclerosis, manufactured and marketed by Novartis.

American brand of ibuprofen pain relief medication owned by Kenvue, the consumer health spinoff from Johnson & Johnson, which is being acquired by Kimberly-Clark in a $40 billion deal announced in November 2025.

Prescription diabetes medication brand owned by Novo Nordisk, containing semaglutide as the active ingredient.

Brand of pain relief medication containing paracetamol (acetaminophen) used for treating mild to moderate pain and fever, manufactured and marketed globally by Haleon.

Oral antiviral medication for COVID-19 treatment containing nirmatrelvir and ritonavir, developed and marketed by Pfizer Pharmaceuticals.

Prescription oncology medication for treating chronic myeloid leukemia, owned by Novartis, facing generic competition after its US patent expired in January 2024, with nilotinib generics now available in the market.

American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023.

Prescription weight loss medication brand owned by Novo Nordisk, containing semaglutide as the active ingredient.

Prescription weight loss medication brand owned by Eli Lilly, containing tirzepatide as the active ingredient.

American brand of cetirizine antihistamine medication used to treat allergies without drowsiness, owned by Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023.